drugset / Trial / NCT04173104

PET and MRI Imaging of Brain Tumors Using [18F]PARPi

NCT04173104 ↗

Phase 0 Completed 5 enrolled Memorial Sloan Kettering Cancer Center
NaSingle-groupOpen-labelDiagnostic

Summary

This study is to collect data about how 18FPARPi can be used together with PET/positron emission tomography and MRI/magnetic resonance imaging scans to take pictures of brain cancer

Timeline

Start
2019-11-01
Primary completion
2026-02-05
Completion
2026-02-05

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]PARPi Diagnostic / imaging agent 100 ug Other